Chemomab Completes Merger with Anchiano Therapeutics Mar 16, 2021 04:45PM
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing Mar 15, 2021 05:54PM
Chemomab Announces First Patient Enrolled in Phase IIa Study of CM-101 for the Treatment of Patients with Primary Sclerosing Cholangitis Feb 2, 2021 09:00AM
Chemomab Announces Positive Phase Ib Results of its SPARK study testing CM-101 in NAFLD patients Jan 5, 2021 08:30AM
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement Dec 15, 2020 09:00AM